Lüscher TF - Search Results

1

Gender and noninvasive diagnosis of coronary artery disease in women and men.

Bürgi Wegmann B, Sütsch G, Rickli H, Seifert B, Muntwyler J, Lüscher TF, Kiowski W, Attenhofer Jost CH. Bürgi Wegmann B, et al. Among authors: luscher tf. J Womens Health (Larchmt). 2003 Jan-Feb;12(1):51-9. doi: 10.1089/154099903321154149. J Womens Health (Larchmt). 2003. PMID: 12639369

2

Endothelin-induced vasoconstriction and calcium antagonists.

Lüscher TF, Yang Z, Kiowski W, Linder L, Dohi Y, Diederich D. Lüscher TF, et al. J Hum Hypertens. 1992 Dec;6 Suppl 2:S3-8. J Hum Hypertens. 1992. PMID: 1289511 Review.

3

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor.

Kiowski W, Lüscher TF, Linder L, Bühler FR. Kiowski W, et al. Among authors: luscher tf. Circulation. 1991 Feb;83(2):469-75. doi: 10.1161/01.cir.83.2.469. Circulation. 1991. PMID: 1846783 Clinical Trial.

4

Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension.

Linder L, Kiowski W, Bühler FR, Lüscher TF. Linder L, et al. Among authors: luscher tf. Circulation. 1990 Jun;81(6):1762-7. doi: 10.1161/01.cir.81.6.1762. Circulation. 1990. PMID: 2344673

5

Age and the platelet serotonin vasoconstrictor axis in essential hypertension.

Amstein R, Fetkovska N, Lüscher TF, Kiowski W, Bühler FR. Amstein R, et al. Among authors: luscher tf. J Cardiovasc Pharmacol. 1988;11 Suppl 1:S35-40. J Cardiovasc Pharmacol. 1988. PMID: 2459512 Review.

6

The coronary artery as a living organ.

Lüscher TF. Lüscher TF. Semin Interv Cardiol. 1998 Mar;3(1):1-4. Semin Interv Cardiol. 1998. PMID: 10094178 No abstract available.

7

Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease.

Maier W, Cosentino F, Lütolf RB, Fleisch M, Seiler C, Hess OM, Meier B, Lüscher TF. Maier W, et al. Among authors: luscher tf. J Cardiovasc Pharmacol. 2000 Feb;35(2):173-8. doi: 10.1097/00005344-200002000-00001. J Cardiovasc Pharmacol. 2000. PMID: 10672847

8

Assessment of cardiovascular risk: time to apply genetic risk factors?

Muntwyler J, Lüscher TF. Muntwyler J, et al. Among authors: luscher tf. Eur Heart J. 2000 Apr;21(8):611-3. doi: 10.1053/euhj.1999.2014. Eur Heart J. 2000. PMID: 10731398 Free article. No abstract available.

9

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators.

Spieker LE, Mitrovic V, Noll G, Pacher R, Schulze MR, Muntwyler J, Schalcher C, Kiowski W, Lüscher TF. Spieker LE, et al. Among authors: luscher tf. J Am Coll Cardiol. 2000 Jun;35(7):1745-52. doi: 10.1016/s0735-1097(00)00649-5. J Am Coll Cardiol. 2000. PMID: 10841220 Free article.

10

Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.

Fleisch M, Sütsch G, Yan XW, Wenzel RR, Binggeli C, Bianchetti MG, Meier B, Kiowski W, Lüscher TF. Fleisch M, et al. Among authors: luscher tf. J Cardiovasc Pharmacol. 2000 Sep;36(3):302-9. doi: 10.1097/00005344-200009000-00004. J Cardiovasc Pharmacol. 2000. PMID: 10975586 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,638 results

Search Page

Filters